Medicure (TSXV:MPH) Dividend Payout Ratio : 0.00 (As of Dec. 2023)

View and export this data going back to 1999. Start your Free Trial

What is Medicure Dividend Payout Ratio?

Medicure's dividend payout ratio for the months ended in Dec. 2023 was 0.00.

The historical rank and industry rank for Medicure's Dividend Payout Ratio or its related term are showing as below:

TSXV:MPH's Dividend Payout Ratio is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.34
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-05-14), the Dividend Yield % of Medicure is 0.00%.

Medicure's Dividends per Share for the months ended in Dec. 2023 was C$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Medicure Dividend Payout Ratio Historical Data

The historical data trend for Medicure's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicure Dividend Payout Ratio Chart

Medicure Annual Data

Trend

May14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dividend Payout Ratio

Get a 7-Day Free Trial

Medicure Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Medicure's Dividend Payout Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Medicure's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medicure's Dividend Payout Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicure's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Medicure's Dividend Payout Ratio falls into.

Medicure Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Medicure's Dividend Payout Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Dec. 2023 )	/	EPS without NRI (A: Dec. 2023 )
	=	0	/	-0.084
	=	N/A

Medicure's Dividend Payout Ratio for the quarter that ended in Dec. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Dec. 2023 )	/	EPS without NRI (Q: Dec. 2023 )
	=	0	/	-0.147
	=	N/A

Medicure (TSXV:MPH) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Medicure Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Medicure's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicure (TSXV:MPH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicure Inc (TSXV:MPH) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

MCUJF:USA NGQ1:Germany

Address

2 - 1250 Waverley Street, Winnipeg, MB, CAN, R3T 6C6

Website

https://www.medicure.com

Medicure Inc is a biopharmaceutical company. It is involved in the research, clinical development, and commercialization of human therapeutics for the United States hospital market. Further, it also operates a specialty pharmacy in the United States of America. The company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and developing its e-commerce and mail order pharmaceutical business. The company operates in two segments namely, Marketing and distribution of commercial products and, Retail and mail order pharmacy. The majority of the company's revenue is generated from the marketing and distribution of the commercial products segment.

Medicure (TSXV:MPH) Headlines

No Headlines